GlucoTrack Inc (GCTK)

HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

$0.89

-0.22 (-20.06%)

Market Cap: $1.04M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26 Reported Aug 14, 2026Reported Aug 14	$-0.76	N/A	-	N/A	Beat	-	-	+96.1%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-4.64	$0.00	-	N/A	Miss	-	-	+99.6%
Jun 30, 2025Jun 25 Reported Aug 14, 2025Reported Aug 14	$-9.62	N/A	-	N/A	Beat	-	-	+99.0%
Mar 31, 2025Mar 25 Reported May 14, 2025Reported May 14	$-40.35	N/A	-	N/A	Beat	-	-	+94.3%
Dec 31, 2024Dec 24 Reported Mar 27, 2025Reported Mar 27	$-19.51	N/A	-	N/A	Beat	-	-	+97.2%
Sep 30, 2024Sep 24 Reported Nov 14, 2024Reported Nov 14	$-1091.07	N/A	-	N/A	Beat	-	-	-87.9%
Jun 30, 2024Jun 24 Reported Aug 13, 2024Reported Aug 13	$-983.76	N/A	-	N/A	Beat	-	-	-200.6%
Mar 31, 2024Mar 24 Reported May 15, 2024Reported May 15	$-703.61	N/A	-	N/A	Beat	-	-	-41.4%
Dec 31, 2023Dec 23 Reported Mar 28, 2024Reported Mar 28	$-692.70	N/A	-	N/A	Beat	-	-	-865773.6%
Sep 30, 2023Sep 23 Reported Nov 14, 2023Reported Nov 14	$-580.70	N/A	-	N/A	Beat	-	-	-967740.3%
Jun 30, 2023Jun 23 Reported Aug 14, 2023Reported Aug 14	$-327.25	N/A	-	N/A	Beat	-	-	-467400.6%
Mar 31, 2023Mar 23 Reported May 12, 2023Reported May 12	$-497.69	N/A	-	N/A	Beat	-	-	-710885.4%
Dec 31, 2022Dec 22 Reported Mar 31, 2023Reported Mar 31	$-0.08	N/A	-	N/A	Beat	-	-	+20.0%
Sep 30, 2022Sep 22 Reported Nov 14, 2022Reported Nov 14	$-0.06	N/A	-	N/A	Beat	-	-	-20.0%
Jun 30, 2022Jun 22 Reported Aug 15, 2022Reported Aug 15	$-0.07	N/A	-	N/A	Beat	-	-	+90.3%
Mar 31, 2022Mar 22 Reported May 16, 2022Reported May 16	$-0.07	N/A	-	N/A	Beat	-	-	-600.0%
Dec 31, 2021Dec 21 Reported Mar 31, 2022Reported Mar 31	$-0.10	N/A	-	N/A	Beat	-	-	+100.0%
Sep 30, 2021Sep 21 Reported Nov 15, 2021Reported Nov 15	$-0.05	N/A	-	N/A	Beat	-	-	-51.5%
Jun 30, 2021Jun 21 Reported Aug 16, 2021Reported Aug 16	$-0.72	N/A	-	N/A	Beat	-	-	-1835.5%
Mar 31, 2021Mar 21 Reported Apr 30, 2021Reported Apr 30	$-0.01	N/A	-	N/A	Beat	-	-	+81.0%
Dec 31, 2020Dec 20 Reported Dec 31, 2020Reported Dec 31	$-341.49	N/A	-	N/A	Beat	-	-	-19.0%
Sep 30, 2020Sep 20 Reported Nov 12, 2020Reported Nov 12	$-0.03	N/A	-	N/A	Beat	-	-	-230.0%
Jun 30, 2020Jun 20 Reported Aug 14, 2020Reported Aug 14	$-0.04	N/A	-	N/A	Beat	-	-	-272.0%
Mar 31, 2020Mar 20 Reported Apr 14, 2020Reported Apr 14	$-0.05	N/A	-	N/A	Beat	-	-	+98.3%
Dec 31, 2019Dec 19 Reported Dec 31, 2019Reported Dec 31	$-286.86	N/A	-	N/A	Beat	-	-	+98.4%
Sep 30, 2019Sep 19 Reported Nov 13, 2019Reported Nov 13	$-0.01	N/A	-	N/A	Beat	-	-	+96.8%
Jun 30, 2019Jun 19 Reported Aug 14, 2019Reported Aug 14	$-0.01	N/A	-	N/A	Beat	-	-	+97.0%
Mar 31, 2019Mar 19 Reported May 15, 2019Reported May 15	$-3.13	N/A	-	N/A	Beat	-	-	-820.6%
Dec 31, 2018Dec 18 Reported Dec 31, 2018Reported Dec 31	$-17848.62	N/A	-	N/A	Beat	-	-	-3797479.0%
Sep 30, 2018Sep 18 Reported Nov 14, 2018Reported Nov 14	$-0.31	N/A	-	N/A	Beat	-	-	+29.5%
Jun 30, 2018Jun 18 Reported Aug 14, 2018Reported Aug 14	$-0.33	N/A	-	N/A	Beat	-	-	+31.2%
Mar 31, 2018Mar 18 Reported May 15, 2018Reported May 15	$-0.34	N/A	-	N/A	Beat	-	-	+29.2%
Dec 31, 2017Dec 17 Reported Mar 30, 2018Reported Mar 30	$-0.47	N/A	-	N/A	Beat	-	-	+100.0%
Sep 30, 2017Sep 17 Reported Nov 14, 2017Reported Nov 14	$-0.44	N/A	-	N/A	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Aug 14, 2017Reported Aug 14	$-0.48	N/A	-	N/A	Beat	-	-	-
Mar 31, 2017Mar 17 Reported May 15, 2017Reported May 15	$-0.48	N/A	-	N/A	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Dec 31, 2016Reported Dec 31	$-18307.47	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-621.00%	ROIC	-6319.21%
Financial Health
Debt/Equity	-1.11x	Interest Coverage	N/A
Current Ratio	0.46x	Quick Ratio	0.46x
Trading Statistics
Beta	0.73	Avg Volume	3.94M
52-Week High	$112.50	52-Week Low	$0.86

Technical Indicators Dashboard

Moving Averages

SMA 10$1.13

SMA 20$1.61

SMA 50$3.36

SMA 200$15.05

EMA 10$1.21

EMA 20$1.66

EMA 50$3.12

EMA 200$21.76

MACD

Line: -0.66Signal: -0.71Hist: 0.06

ADX

ADX: 16.3+DI: 9.7-DI: 12.9

Aroon & PSAR

Aroon UpN/A

Aroon Down100.0

PSAR$2.11

Bollinger Bands

Upper Band$2.72

Lower Band$0.50

%B Position13747%(Upper)

Band Width0.17

RSI (14-Day)

Oversold

27.2

Momentum Oscillators

Stoch %K4.6

Stoch %D4.2

Williams %R-98.3

ROC (10d)-45.9%

Momentum-0.75

CCI (20d)-93.1

MFI (14d)4.5

Volatility Measures

ATR (14d)$0.72(81.6%)

StdDev (20d)0.55

Hist Vol187.5%(High)

Volume Flow

VWAP$0.95

OBV646.9M

AD Line3520.7B

CMF (20d)-0.606

Volume Metrics

Avg Vol (20d)4.3M

Vol Ratio0.1x(Low)

VWMA (20d)$2.32

Pivot Points

R3$1.25

R2$1.20

R1$1.16

Pivot Point$1.11

S1$1.07

S2$1.02

S3$0.98

Advanced Oscillators

TSI-42.07

Ultimate Osc36.2

KST-619.92

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$0	$0	$0	$0	$0	$0	$24,000	$0	$0	$0	$42,000	$0
Cost of Revenue	$0	$0	$14,000	$0	$0	$0	$14,000	$0	$0	$0	$21,000	$0
Gross Profit	$0	$0	$-14,000	$0	$0	$0	$-14,000	$0	$0	$0	$21,000	$0

Operating Expenses	$3.40M	$4.20M	$3.49M	$4.31M	$4.80M	$3.50M	$3.85M	$3.25M	$4.49M	$2.95M	$2.42M	$2.22M
R&D	$2.02M	$2.13M	$1.63M	$3.17M	$3.15M	$1.87M	$1.70M	$2.06M	$3.59M	$2.15M	$1.74M	$1.69M
SG&A	$1.38M	$2.07M	$2.29M	$1.02M	$1.65M	$1.63M	$2.45M	$1.06M	$802,000	$733,000	$553,000	$531,000
Operating Income	$-3,400,000	$-4,203,000	$-3,487,000	$-4,309,000	$-4,796,000	$-3,498,000	$-3,854,000	$-3,251,000	$-4,491,000	$-2,951,000	$-2,417,000	$-2,224,000

Interest Income	$0	$0	$0	$2,000	$29,000	$0	$0	$-1,848,000	$2,000	$0	$0	$0
Interest Expense	$414,000	$131,000	$141,000	$0	$0	$3.33M	$6.22M	$1.84M	$0	$0	$2,000	$0
Income Before Tax	$-3,814,000	$-4,334,000	$-3,628,000	$-4,171,000	$-4,756,000	$-6,833,000	$-10,070,000	$-5,087,000	$-4,489,000	$-2,951,000	$-2,419,000	$-2,223,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-3,814,000	$-4,334,000	$-3,628,000	$-4,171,000	$-4,756,000	$-6,833,000	$-10,094,000	$-5,087,000	$-4,489,000	$-2,927,000	$-2,412,000	$-2,223,000

EBITDA	$-3,643,000	$-4,164,000	$-3,437,000	$-4,133,000	$-4,772,000	$-6,822,000	$-11,604,000	$-2,899,000	$-4,483,000	$-2,947,000	$-2,427,000	$-2,209,000
EBIT	$-3,814,000	$-4,334,000	$-3,597,000	$-4,173,000	$-4,785,000	$-6,833,000	$-11,916,000	$-3,239,000	$-4,491,000	$-2,951,000	$-2,419,000	$-2,223,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about GCTK

News

A free app compares medication results, side effects and costs with people like you

Lōkahi Therapeutics, a subsidiary of Glucotrack, Inc., has launched Qare, a free app designed to help users compare self-reported treatment experiences for GLP-1 medications. The app matches users into cohorts based...

Stock Titan•Oct 14, 2026 6:12 PM ET10/14/26•Somewhat-Bullish

Form S-1/A GlucoTrack Inc For: 14 October By Investing.com

This article announces that GlucoTrack Inc. filed a Form S-1/A on October 14. The filing is brief and includes no further details...

Investing.com UK•Oct 14, 2026 6:09 AM ET10/14/26•Bearish

After a 1-for-15 reverse split, Glucotrack (GCTK) updates its illustrative combined-company losses.

Glucotrack (GCTK) has updated its unaudited pro forma financial statements following its merger with Lokahi Therapeutics and a 1-for-15 reverse stock split. The illustrative combined statements show net losses of $19.7...

Stock Titan•Oct 13, 2026 5:13 PM ET10/13/26•Somewhat-Bearish

Glucotrack Updates Pro Forma Financials Following 1-for-15 Reverse Stock Split

Glucotrack, Inc. has updated its pro forma financial statements following a 1-for-15 reverse stock split that became effective on August 28...

Kalkine Media•Oct 13, 2026 5:13 PM ET10/13/26•Somewhat-Bearish

Patients may soon compare medication experiences with others like them.

Lōkahi Therapeutics, a subsidiary of Glucotrack, Inc., announced the upcoming public availability of its Qare™ platform on October 14...

Stock Titan•Sep 30, 2026 8:59 AM ET9/30/26•Bullish

GCTK Valuation and Fair Value

P/B: -0.2x

See GNG's fair value

GCTK Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROIC: -6319.2%
ROE: -621.0%

GCTK Competitors

Company	Ticker
Bone Biologics Corp	BBLG
SAB Biotherapeutics Inc	SABSW
Scinai Immunotherapeutics Ltd	SCNI
Profusa, Inc. Common Stock	PFSA
VSee Health, Inc.	VSEE
Venus Concept Inc	VERO
Mobile-health Network Solutions Class A Ordinary Shares	MNDR
CERo Therapeutics Holdings, Inc. Common Stock	CERO

Sector: Healthcare

Frequently Asked Questions About GCTK

Does GCTK pay dividends?

GlucoTrack Inc (GCTK) does not currently pay a regular dividend.

What is GCTK's market cap?

GlucoTrack Inc (GCTK) has a market capitalization of $1.04M with a current stock price of $0.89.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In